Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Hansoh Pharmaceutical Group Company Limited
3692Health technology
$32.7B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Hansoh Pharmaceutical Group Company Limited appears to be Failed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)7.50%
Non-Permissible
$995
Total Income
$13.3K
Revenue Breakdown
Sales of goods – at a point in time
$10.7K
Collaboration revenue – at a point in time
$1.6K
Bank interest income
Non-Operating
$995
Non-Compliant: $995
Financial Screening
FYE 2024
Cash (<30%)25.18%
Non-Shariah Cash Items
Cash And Cash Equivalents$22.6B
Other Short Term Investments$764.7M
Liabilities (<30%)0.13%
Non-Shariah Liabilities
Current Capital Lease Obligation$16M
Long Term Debt-
Long Term Capital Lease Obligation$61M
Current Debt$40.9M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2026-02-02
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
